Real-world effectiveness and safety of sofosbuvir and nonstructural protein 5A inhibitors for chronic hepatitis C genotype 1, 2, 3, 4, or 6: a multicentre cohort study
索非布韦和非结构蛋白5A抑制剂治疗慢性丙型肝炎基因1、2、3、4或6型的真实世界疗效和安全性:一项多中心队列研究
期刊:BMC Gastroenterology
影响因子:2.6
doi:10.1186/s12876-020-01196-0
Charatcharoenwitthaya, Phunchai; Wongpaitoon, Virasak; Komolmit, Piyawat; Sukeepaisarnjaroen, Wattana; Tangkijvanich, Pisit; Piratvisuth, Teerha; Sanpajit, Theeranun; Sutthivana, Chinnavat; Bunchorntavakul, Chalermrat; Sobhonslidsuk, Abhasnee; Chonprasertsuk, Soonthorn; Siripipattanamongkol, Chotipong; Sethasine, Supatsri; Tanwandee, Tawesak